Shareholder Information

  • UK City Code on Takeovers and Mergers
  • Other exchanges and trading platforms
  • Number of AIM securities in issue
  • Significant shareholdings
  • Director shareholdings
  • Shares not in public hands
  • Restrictions in transfer of AIM Securities

 

UK City Code on Takeovers and Mergers

 

The Company is subject to the provisions of the City Code on Takeovers and Mergers.

 

Other exchanges and trading platforms

 

Trellus Health has not applied or agreed to have any of its securities admitted or traded on any other exchanges or trading platforms.

 

Number of AIM securities in issue

 

161,508,333 shares are issued, called up and fully paid. The Company holds no shares in treasury.
This figure should be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company, under the Disclosure and Transparency Rules.

 

Significant shareholdings

 

Significant shareholders

No. of ordinary shares

% held

Icahn School of Medicine at Mount Sinai

40,384,897

25.0%

Dowgate Group Limited

11,853,038

7.3%

Marla Dubinsky

8,750,500

5.4%

Laurie Keefer

8,759,351

5.4%

Unicorn Asset Management Limited


6,250,000


3.9%

Ian Amiee, Daryl Amiee, Doolittle act Amiee SSAS

5,365,000

3.3%







 

Director Shareholdings

 

Director

Number

Ordinary Shares %

Marla Dubinsky

8,750,500

5.4%

Mike Salter 

1,126,026

.7%







 

Shares not in public hands

 

Percentage of securities not in public hands: As at 10 September 2024 the percentage of AIM securities not in the public hands was 31.12%. The securities not in public hands include all substantial over 10% shareholders and the directors and senior management who are classed as persons discharging managerial responsibilities.

 

Restrictions in transfer of AIM Securities

 

There are no restrictions on the transfer of the Company’s ordinary shares.

 

Last updated: 10 September 2024